BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27645522)

  • 1. Unexplained Bone Pain Is an Independent Risk Factor for Bone Metastases in Newly Diagnosed Prostate Cancer: A Prospective Study.
    Zacho HD; Mørch CD; Barsi T; Mortensen JC; Bertelsen H; Petersen LJ
    Urology; 2017 Jan; 99():148-154. PubMed ID: 27645522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Scan Index Is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: A Prospective Study.
    Zacho HD; Gade M; Mortensen JC; Bertelsen H; Boldsen SK; Barsi T; Petersen LJ
    Urology; 2017 Oct; 108():135-141. PubMed ID: 28760556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng/ml and Gleason score of <=6 at the initial stage of diagnosis.
    Tanaka N; Fujimoto K; Shinkai T; Nakai Y; Kuwada M; Anai S; Miyake M; Hirayama A; Hasegawa M; Hirao Y
    Jpn J Clin Oncol; 2011 Oct; 41(10):1209-13. PubMed ID: 21862505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
    Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
    Jaukovic L; Adjinovic B; Cerovic S; Joksimovic M; Soldatovic Z
    Hell J Nucl Med; 2011; 14(2):126-30. PubMed ID: 21761013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
    Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
    Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
    Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
    Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective multicenter study of bone scintigraphy in consecutive patients with newly diagnosed prostate cancer.
    Zacho HD; Barsi T; Mortensen JC; Mogensen MK; Bertelsen H; Josephsen N; Petersen LJ
    Clin Nucl Med; 2014 Jan; 39(1):26-31. PubMed ID: 24217537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
    KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H
    BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer.
    Wolff JM; Bares R; Jung PK; Buell U; Jakse G
    Urol Int; 1996; 56(3):169-73. PubMed ID: 8860738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan.
    Szot W; Kostkiewicz M; Zając J; Owoc A; Bojar I
    Ann Agric Environ Med; 2014; 21(4):888-92. PubMed ID: 25528940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
    Wang TY; Chen XP; Li XS; Jia Yx; Cheng J; Zhang JH; Cai L; Zhang Z; Gong K; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 44(4):528-34. PubMed ID: 22898839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between pain and skeletal metastasis in patients with prostate or breast cancer.
    Levren G; Sadik M; Gjertsson P; Lomsky M; Michanek A; Edenbrandt L
    Clin Physiol Funct Imaging; 2011 May; 31(3):193-5. PubMed ID: 21114613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone scintigraphy in prostatic cancer. Correlation with clinical and laboratory features and with survival].
    Lobo G; Ladrón de Guevara D; Salgado G; Donoso G; Bagus F
    Rev Med Chil; 1999 Feb; 127(2):181-8. PubMed ID: 10436698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study.
    Lin Y; Mao Q; Chen B; Wang L; Liu B; Zheng X; Xie L
    BMC Urol; 2017 Jun; 17(1):41. PubMed ID: 28606069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of computer-assisted analysis of skeletal lesions for the staging of prostate cancer.
    Petersen LJ; Mortensen JC; Bertelsen H; Zacho HD
    BMC Med Imaging; 2017 Jul; 17(1):40. PubMed ID: 28693433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of prostatic specific antigen, tumor grade, and local stage with bone scintigraphy in the staging of patients with prostatic cancer].
    Herranz Amo F; Díez Cordero JM; Verdú Tartajo F; Lledó García E; Subirá Castillón C; González Chamorro F; Rodríguez Fernández E
    Arch Esp Urol; 1997 Apr; 50(3):253-8. PubMed ID: 9144973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen, Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan.
    Ishizuka O; Tanabe T; Nakayama T; Kawakami M; Kinebuchi Y; Nishizawa O
    Int J Urol; 2005 Aug; 12(8):728-32. PubMed ID: 16174046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there still a role for computed tomography and bone scintigraphy in prostate cancer staging? An analysis from the EUREKA-1 database.
    Gabriele D; Collura D; Oderda M; Stura I; Fiorito C; Porpiglia F; Terrone C; Zacchero M; Guiot C; Gabriele P
    World J Urol; 2016 Apr; 34(4):517-23. PubMed ID: 26276152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma.
    Bayley A; Milosevic M; Blend R; Logue J; Gospodarowicz M; Boxen I; Warde P; McLean M; Catton C; Catton P
    Cancer; 2001 Jul; 92(2):303-10. PubMed ID: 11466683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.